Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Pharmaceutical Collaborations and Rare Diseases Drive the Drugs to Watch as New Blockbusters Are Forecast to Hit the Market in 2019 2019-03-20 16:00
P-MEC China to Arrive in June as Shanghai Gathers International Advanced Pharmaceutical Equipment 2019-03-20 15:00
ConnectedLife and Ocean Protocol Partner to combat Parkinson's Disease 2019-03-20 12:30
WuXi Biologics Receives EMA GMP Certificates 2019-03-20 08:07
UK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Says 2019-03-20 08:00
I-Mab Biopharma and MorphoSys Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma 2019-03-20 05:05
ACell Enters Exclusive South Korean Distribution Agreement for Wound Management Product Line 2019-03-19 18:55
Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China 2019-03-19 18:30
I-Mab Biopharma Announces Dosing of First Subject in Phase 1 Clinical Trial of Anti-GM-CSF Monoclonal Antibody TJM2 in the United States 2019-03-19 18:00
Concord Medical Announces New Appointments to Management Team 2019-03-19 17:40
Nyxoah Receives European CE Mark Approval for the Genio® System, a Disruptive Neurostimulation Solution for Obstructive Sleep Apnea Therapy 2019-03-19 16:00
NeuroVive Enrolls First Subject in its KL1333 Phase Ia/b Clinical Study 2019-03-19 15:58
Envirotainer Opens RAP e2 and RKN e1 Station in Mumbai, India 2019-03-19 15:23
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S. 2019-03-19 08:09
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD 2019-03-18 23:58
WuXi Biologics Continues to Deliver Record Results 2019-03-18 22:25
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Approved for Australian Women(1) 2019-03-18 20:45
CSPC Pharmaceutical Announces 2018 Annual Results 2019-03-18 12:18
VolitionRx Limited to Present at Conferences in the U.S. Next Week 2019-03-15 20:30
Adlai Nortye's Buparlisib (AN2025) Set to Become a Potential Treatment for Anti-PD-1 Non-responding Tumor in HNSCC 2019-03-15 17:06
1 930 931 932 933 934 1627